News & Articles

Designed to support drug developers in bringing their therapeutics to market faster, more efficiently, and with greater reliability

Offering early access to the new diagnostic paradigm, pilot partnerships with selected institutions engaged by year-end

Elecsys pTau181 is the first in vitro diagnostic regulation (IVDR)-certified test to rule out Alzheimer’s associated amyloid pathology

Designed for use in decentralized, CLIA-waived settings, the test has been analytically verified in a study to deliver results comparable to standard laboratory methods

Breakthrough data validates capabilities of GlueSEEKER platform to identify novel induced protein-protein interactions and expand druggable space

The Runge mikron 91 inline pH probe is a full-fledged liquid chromatography detector squeezed into a tiny format

The new software is offered as a free upgrade for existing customers

New assay provides clinical research labs with an all-in-one comprehensive genomic profiling solution that delivers next-day results

Three-in-one system integrates large fragment analytics, DNA size selection and fluorometric quantification for long-read sequencing

Integration of firefly liquid handling platform and SemaCyte microcarriers enables flexible, miniaturized, and automated cell assay workflows

Intuitive software supports 24 hours of continuous runtime and easy analysis of complex high-throughput datasets

Collaboration is working to improve tracking and labelling of samples

Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer generates results in as little as 24 hours to support timely therapy decisions

Ideal for a variety of lab sizes, from medium to large, the P780 is engineered for high reliability, offering an innovative and scalable solution

A nasal vaccine could prove both more effective medically and more tolerable for young children and adults who may fear needles

Restek’s two new multicomponent PFAS certified reference materials will minimize errors, save time, and decrease costs

Ideal for researchers requiring a rapid, reproducible, and scalable means of generating specific neural cell types without sacrificing cell purity

Recognition underscores Bruker’s commitment to sustainability and innovation in microbial detection

Aiforia Breast Cancer Grading AI solution is a part of the Aiforia Breast Cancer Suite, which also includes CE-IVD marked AI models for breast cancer biomarkers and the Aiforia Clinical Suite Viewer.

The FS5 v2 sets a new standard in fluorescence spectroscopy with its enhanced sensitivity, expanded capabilities, and compact user-friendly design

New research shows integrated services can reduce Phase I-III study times by up to nearly three years, generating strong ROI for biotech and biopharma customers

Platform is built on biologically labelled, organ-specific multi-omics data carried by extracellular vesicles isolated from 2ml plasma samples

Minimizes common user errors by up to 40% and enhances audit readiness by providing end-to-end traceability and data integrity

Additions to company’s range of bioanalytical antibodies and reagents enhances bioanalysis and antibody-related research